Rhenman & Partners Asset Management AB
Position in AVR — Anteris Technologies Global Corp.
CIK 1599882
Stockholm, V7
Position in AVR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,155,456
+$7,171,088 QoQ
Shares Held
1,538,625
+7.0% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#13
of 135 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $158,344,141 across 16 Medical Devices names. AVR ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
260,000 | $23,519,600 | |
| 2 | SYK |
Stryker Corp
|
65,000 | $20,464,600 | |
| 3 | BSX |
Boston Scientific Corp
|
450,500 | $19,227,340 | |
| 4 | GKOS |
GLAUKOS Corp
|
119,000 | $16,631,440 | |
| 5 | AVR |
Anteris Technologies Global Corp.
This page
|
1,538,625 | $15,155,456 | |
| 6 | LIVN |
LivaNova PLC
|
164,000 | $13,485,720 | |
| 7 | MDT |
Medtronic plc
|
145,000 | $11,343,350 | |
| 8 | DXCM |
Dexcom Inc
|
160,000 | $10,776,000 |
All Filings in AVR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,155,456 | 1,538,625 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,984,368 | 1,438,625 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,180,738 | 1,238,625 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,628,433 | 1,250,763 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,740,391 | 1,250,763 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,695,600 | 1,290,000 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||